Supplement guide

Flaxseed Oil

Learn about the uses, forms, amounts, and precautions for Flaxseed Oil. This guide brings the relevant conditions together so you can see who the information covers, how preparations differ, and what to consider before use.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team · Sources and editorial method

First released · Updated · View changes

What is it used for?

All products

  • Source of essential fatty acids (alpha-linolenic acid (ALA) and linoleic acid (LA)) for the maintenance of good health [Source note 2].

  • Source of omega-3 fatty acids for the maintenance of good health [Source note 3].

  • Source of alpha-linolenic acid (ALA) for the maintenance of good health [Source note 4].

  • Source of omega-6 fatty acids for the maintenance of good health [Source note 5].

  • Source of linoleic acid (LA) for the maintenance of good health [Source note 6].

Note: The above uses can be combined on the product label (e.g., Source of omega-3 and omega-6 fatty acids for the maintenance of good health).

What this guide covers

  • The solidus (/) indicates that the terms and/or statements are synonymous. Either term or statement may be selected by the applicant on the label.

Who does this guide cover?

As specified below.

How is it taken?

Oral

Which forms are covered?

this reference excludes foods or food-like dosage forms as indicated in the Compendium of references Guidance Document.

Acceptable Dosage Form(s)by Age Group

Children 2 years: The acceptable dosage forms are limited to emulsion/suspension and solution/liquid preparations (Giacoia et al. 2008; EMA/CHMP 2006).

Children 3-5 years: The acceptable dosage forms are limited to chewables, emulsion/suspension, powders and solution/liquid preparations (Giacoia et al. 2008; EMA/CHMP 2006).

Children 6-11 years, Adolescents 12-17 years, and Adults 18 years and older: The

Quantities

Method of preparation: Non-standardized fixed oil

Table 2.Dose information for Linseed oil presented as dose per day, based on uses or purposes and subpopulations.
Uses or PurposesSubpopulations¹,²Subpopulations¹,²Oil g/day / Min.Oil g/day / Max.Oil ml/day / Min.Oil ml/day / Max.
Source of essential fatty acids, omega-3 fatty acids, and/or ALAChildren2-4 years0.045.330.175.67
Source of essential fatty acids, omega-3 fatty acids, and/or ALAChildren5-9 years0.0680.258.50
Source of essential fatty acids, omega-3 fatty acids, and/or ALAChildren10-11 years0.12160.517
Source of essential fatty acids, omega-3 fatty acids, and/or ALAAdolescents12-14 years0.12160.517
Source of essential fatty acids, omega-3 fatty acids, and/or ALAAdolescents15-17 years0.2332134
Source of essential fatty acids, omega-3 fatty acids, and/or ALAAdults18 years and older0.2332134
Source of omega-6 fatty acids and/or LAChildren2-4 years1.285.331.335.67
Source of omega-6 fatty acids and/or LAChildren5-9 years1.93828.50
Source of omega-6 fatty acids and/or LAChildren10-11 years3.8516417
Source of omega-6 fatty acids and/or LAAdolescents12-14 years3.8516417
Source of omega-6 fatty acids and/or LAAdolescents15-17 years7.7032834
Source of omega-6 fatty acids and/or LAAdults18 years and older7.7032834

¹Children and adolescent doses were calculated as a proportion of the adult dose [Source note 7]. The use of Flaxseed oil in children and adolescents is supported by Bove 2001.

²Adult dose supported by the following references: IOM 2006; Schwab et al. 2006; Nordström et al. 1995; Kelley et al. 1993; Fischer et al. 1984.

Method of preparation: Standardized fixed oil

If potencies are declared, the only acceptable potencies are as follows:

Note: The following potency information is considered as additional information and can be included on the label:

  • 11-35% oleic acid [Source note 10]

  • XX% total omega-3 fatty acids

  • XX% total omega-6 fatty acids

How is it used?

The reference does not require an additional label statement in this section. This does not establish an absence of risk.

How long is it used?

The reference does not require an additional label statement in this section. This does not establish an absence of risk.

Warnings and precautions

The reference does not require an additional label statement in this section. This does not establish an absence of risk.

When should it be avoided?

The reference does not require an additional label statement in this section. This does not establish an absence of risk.

Possible side effects

The reference does not require an additional label statement in this section. This does not establish an absence of risk.

Storage

Must be established in accordance with the requirements described in the applicable product regulations.

All products, except those encapsulated

Refrigerate after opening [Source note 11].

All products (information for industry; not for labelling)

To be packaged in airtight container, protected from light [Source note 12].

Preparation details

Ingredient identity, preparation requirements, and other details that define the scope of this guide.

Ingredients and preparations
Table 1. Proper name(s), Common name(s), Source information
Proper name(s)Common name(s)Source information / Source material(s)Source information / Part(s)
Linum usitatissimum
  • Flax Oil
  • Flaxseed Oil
  • Linseed Oil
Linum usitatissimumSeed

References: Proper name: USDA 2024; Common names: Brayfield and Cadart 2024, Ph. Eur. 2023, Hoffman 2003, Hendler and Rorvik 2001; Source information: Brayfield and Cadart 2024.

Other ingredients

Must be chosen from the current source ingredient database and must meet the limitations outlined in the database.

Preparation and quality requirements
  • The finished product specifications must be established in accordance with the requirements described in the source authority source’s product quality guidance.

  • The active ingredient must comply with the requirements outlined in the source ingredient database.

  • For products indicating one or more of the optional potencies listed in the dose section, an assay must be performed in order to confirm the potency(ies).

Guide change history

Updates to this SupplementSafety.org guide.

  1. Minor updates

    Updated guide wording, organization, and source presentation. Added our editorial change history.

  2. Initial release

    Initial SupplementSafety.org guide prepared from source reference material.

Validation: Not yet completed. Editorial updates do not constitute clinical validation.

Sources

Source information

This guide organizes source material about uses, preparations, amounts, and precautions. Read the conditions alongside each statement; the information may apply only to particular preparations or populations.

The source document includes supporting references. We have not independently summarized or assessed every cited study for this guide.

Source document version
April 25, 2025
Source captured
Aug 15, 2026
Editorial work
Editorial preparation. Independent clinical review has not been recorded for this guide.

Full citations are available through the link above. Verification is required to open them; reading this guide does not require verification.

Taking a medication too?

Explore our supplement–medication interaction checker. Its coverage and review status are shown with the results; a missing finding does not establish that a combination is safe.

Browse all supplement guides →